Neuroimmune crosstalk through brain-derived neurotrophic factor and its precursor pro-BDNF: New insights into mood disorders

doi:10.5498/wjp.v12.i3.379

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5164)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

264

WORD

120

HTML

2587

Figures (1-2)

349

Sum=3320

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

220

Download

526

Sum=746

Publishing Process of This Article

Item

Count

Browse

354

Download

744

Sum=1098

Mar 19, 2022 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Psychiatry. Mar 19, 2022; 12(3): 379-392
Published online Mar 19, 2022. doi: 10.5498/wjp.v12.i3.379

Neuroimmune crosstalk through brain-derived neurotrophic factor and its precursor pro-BDNF: New insights into mood disorders

Xiao-Pei Zhao, Hui Li, Ru-Ping Dai

Xiao-Pei Zhao, Hui Li, Ru-Ping Dai, Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China

Author contributions: Zhao XP collected the data and wrote the paper; Li H and Dai RP collected the data and supervised the writing of the paper.

Supported by National Natural Science Foundation of China, No. 82071347 and No. 81771354 (to Dai RP).

Conflict-of-interest statement: The authors declare no conflict of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Ru-Ping Dai, MD, PhD, Academic Research, Chief Doctor, Director, Doctor, Professor, Department of Anesthesiology, The Second Xiangya Hospital, Central South University, No. 139 Renmin Middle Road, Changsha 410011, Hunan Province, China. xyeyyrupingdai@csu.edu.cn

Received: March 29, 2021
Peer-review started: March 29, 2021
First decision: August 19, 2021
Revised: August 22, 2021
Accepted: January 22, 2022
Article in press: January 22, 2022
Published online: March 19, 2022
Processing time: 348 Days and 1.7 Hours

Core Tip

Core Tip: The neuroimmune crosstalk plays a crucial role in the regulation of mood disorders. Recent studies have shown that the brain-derived neurotrophic factor (BDNF) and its precursor pro-BDNF are cardinal regulators in the neuroimmune axis. However, the roles and potential mechanisms of BDNF/pro-BDNF signaling in the neuroimmune crosstalk in the context of mood disorders remain unexplored. In this review, we summarize recent studies on the role of BDNF/TrkB signaling and pro-BDNF/p75^NTR signaling in the neuroimmune axis and how they influence the development of mood disorders.